经会阴与经直肠磁共振成像靶向穿刺活检检测前列腺癌的系统评价与Meta分析
该系统评价与Meta分析检索Cochrane、Embase、Ovid和PubMed至2023年1月,共纳入15项记录、8826例患者,比较经会阴(TP)与经直肠(TR)磁共振成像靶向活检(MRI-TB)对前列腺癌(PCa)和临床显著前列腺癌(csPCa)的检出率。结果显示TP MRI-TB检出PCa更多(RR 1.25,95%CI 1.12–1.39,p<0.0001),按患者分析检出csPCa更多,前列腺前区检出csPCa更多,但按病灶分析两种途径检出csPCa相当;作者提示需谨慎看待结果,因纳入研究存在异质性。
要点
- TP MRI-TB检出PCa多于TR MRI-TB:RR 1.25(95%CI 1.12–1.39,p<0.0001)。
- 按患者分析TP MRI-TB检出csPCa更多:一项队列RR 1.33(95%CI 1.09–1.63,p=0.005),两项队列RR 1.37(95%CI 1.16–1.61,p=0.0002)。
- 前列腺前区TP MRI-TB检出csPCa更多:按病灶RR 1.52(95%CI 1.04–2.23,p=0.03),按患者RR 2.55(95%CI 1.56–4.16,p=0.0002)。
核心结论
- TP MRI-TB在检测PCa和csPCa方面比TR MRI-TB更有效,检测位于前区的csPCa结果仍显著。
- 作者指出,尽管纳入研究存在异质性,结果仍需谨慎对待。
研究设计与样本
- 系统评价与Meta分析,检索Cochrane、Embase、Ovid和PubMed至2023年1月,共识别1482条文献,最终纳入15项记录,合计8826例患者。
- 合并经会阴与经直肠MRI靶向活检检出PCa和csPCa的相对灵敏度(RR)及95%CI。
主要发现
- TP MRI-TB检出PCa多于TR:RR 1.25(95%CI 1.12–1.39,p<0.0001)。
- 同时或分别接受TP MRI-TB与TR MRI-TB的患者中,按患者分析TP MRI-TB检出csPCa更多:一项队列RR 1.33(95%CI 1.09–1.63,p=0.005),两项队列RR 1.37(95%CI 1.16–1.61,p=0.0002)。
- 按病灶分析,TP与TR途径检出csPCa相当:RR 0.91(95%CI 0.76–1.08,p=0.28)。
- 前列腺前区,TP MRI-TB检出csPCa更多:按病灶RR 1.52(95%CI 1.04–2.23,p=0.03),按患者RR 2.55(95%CI 1.56–4.16,p=0.0002)。
关键数值与推荐
- TP MRI-TB检出PCa的RR 1.25(95%CI 1.12–1.39,p<0.0001)。
- 按患者分析TP MRI-TB检出csPCa:一项队列RR 1.33(95%CI 1.09–1.63,p=0.005),两项队列RR 1.37(95%CI 1.16–1.61,p=0.0002)。
- 按病灶分析TP与TR检出csPCa:RR 0.91(95%CI 0.76–1.08,p=0.28)。
- 前区csPCa检出:按病灶RR 1.52(95%CI 1.04–2.23,p=0.03),按患者RR 2.55(95%CI 1.56–4.16,p=0.0002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出纳入研究存在异质性,结果需谨慎对待。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Magnetic resonance imaging (MRI) has deeply altered the prostate biopsy strategy to detect prostate cancer. However, it is still debatable whether the detection rate differs between transrectal (TR) and transperineal (TP) MRI-targeted biopsy (MRI-TB). To compare the effectiveness of these two methods for detecting both overall prostate cancer (PCa) and clinically significant PCa (csPCa), We performed a review and meta-analysis. METHODS: Until January 2023, we conducted a thorough search of Cochrane, Embase, Ovid, and PubMed. In total, 1482 references were identified, and 15 records were finally included. For PCa and csPCa discovered by TP and TR MRI-TB, we combined the relative sensitivity (RR) with 95% confidence intervals (CI). The RR between the TP and TR routes was established. RESULTS: Our study included 8826 patients in total and revealed that TP MRI-TB detected more PCa (RR 1.25 [95% CI 1.12, 1.39], p < 0.0001). In patients who underwent TP MRI-TB and TR MRI-TB at the same time or separately, TP MRI-TB had a greater detection rate of csPCa in per-patient analysis (one cohort (RR 1.33 [95% CI 1.09, 1.63], p = 0.005); two cohorts (RR 1.37 [95% CI 1.16, 1.61], p = 0.0002)). However, the detection rate of csPCa between the TP route and the TR route was comparable in per-lesion analysis (RR 0.91 [95% CI 0.76, 1.08], p = 0.28). Additionally, in the prostate's anterior region, we found that TP MRI-TB detected more csPCa (per-lesion (RR 1.52 [95% CI 1.04, 2.23], p = 0.03); per-patient (RR 2.55 [95% CI 1.56, 4.16], p = 0.0002)). CONCLUSION: According to this comprehensive study, TP MRI-TB is more effective than TR MRI-TB at detecting PCa and csPCa. Significant results persisted for detecting csPCa located in the anterior zone. The results need to be taken carefully notwithstanding the heterogeneity among the included studies.
引用
- Wu Q, Tu X, Zhang C, et al. Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2023. PMID: 37783837. doi:10.1038/s41391-023-00729-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。